TRLS-01. Trial in Progress: A Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine PET in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE)

Rupesh R Kotecha; Alain Chaglassian; Nancy Tainer; Eugene Teoh

TRLS-01. Trial in Progress: A Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine PET in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE)

Rupesh R Kotecha
, Alain Chaglassian
, Nancy Tainer
, Eugene Teoh

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-Oncology Advances
Volume	3
State	Published - Aug 3 2021

Disciplines

Medicine and Health Sciences

Cite this

TRLS-01. Trial in Progress: A Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine PET in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE). / Kotecha, Rupesh R; Chaglassian, Alain; Tainer, Nancy et al.
In: Neuro-Oncology Advances, Vol. 3, 03.08.2021.

Research output: Contribution to journal › Article › peer-review

@article{752552eac1594c849b17c163c8491663,

title = "TRLS-01. Trial in Progress: A Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine PET in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE)",

author = "Kotecha, \{Rupesh R\} and Alain Chaglassian and Nancy Tainer and Eugene Teoh",

year = "2021",

month = aug,

day = "3",

language = "American English",

volume = "3",

journal = "Neuro-Oncology Advances",

}

TY - JOUR

T1 - TRLS-01. Trial in Progress: A Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine PET in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE)

AU - Kotecha, Rupesh R

AU - Chaglassian, Alain

AU - Tainer, Nancy

AU - Teoh, Eugene

PY - 2021/8/3

Y1 - 2021/8/3

M3 - Article

VL - 3

JO - Neuro-Oncology Advances

JF - Neuro-Oncology Advances

ER -